STOCK TITAN

Bioventus (BVS) CFO exercises 13,000 RSUs and withholds 5,648 shares for tax

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Bioventus Inc. senior vice president and CFO Mark Leonard Singleton reported routine equity compensation activity involving Class A common stock and restricted stock units. On April 10, 2026, he exercised 13,000 restricted stock units, receiving an equal number of Class A shares at a conversion price of $0.00 per share.

To cover related tax obligations, 5,648 Class A shares were disposed of through a tax-withholding transaction at $9.06 per share, a non‑market “F” code event rather than an open‑market sale. After these transactions, Singleton directly owned 182,981 Class A shares, reflecting a net increase in his equity position from this vesting and withholding sequence.

Positive

  • None.

Negative

  • None.
Insider Singleton Mark Leonard
Role SVP & CFO
Type Security Shares Price Value
Exercise Restricted Stock Units 13,000 $0.00 --
Exercise Class A Common Stock 13,000 $0.00 --
Tax Withholding Class A Common Stock 5,648 $9.06 $51K
Holdings After Transaction: Restricted Stock Units — 13,000 shares (Direct); Class A Common Stock — 182,981 shares (Direct)
Footnotes (1)
  1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date.
RSUs exercised 13,000 units Restricted stock units converted to Class A common stock on April 10, 2026
Tax-withholding shares 5,648 shares Class A common stock withheld to cover tax at $9.06 per share
Tax-withholding reference price $9.06 per share Price used for 5,648-share tax-withholding disposition
Shares owned after transactions 182,981 shares Direct Class A common stock holdings following April 10, 2026 transactions
RSU conversion price $0.00 per unit Conversion of 13,000 RSUs into Class A shares
Restricted Stock Units financial
"The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax-withholding disposition financial
"transaction_action: "tax-withholding disposition" for 5,648 Class A common shares"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
derivative exercise/conversion financial
"transaction_action: "derivative exercise/conversion" for 13,000 restricted stock units"
Class A Common Stock financial
"security_title: "Class A Common Stock" in the non-derivative transactions"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Singleton Mark Leonard

(Last)(First)(Middle)
4721 EMPEROR BOULEVARD, SUITE 100

(Street)
DURHAM NORTH CAROLINA 27703

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Bioventus Inc. [ BVS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP & CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock04/10/2026M13,000A$0182,981D
Class A Common Stock04/10/2026F5,648D$9.06177,333D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)04/10/2026M13,000 (2) (2)Class A Common Stock13,000$013,000D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
2. The RSUs shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date.
Remarks:
/s/ Anthony D'Adamio, Attorney-in-Fact04/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Bioventus (BVS) CFO Mark Singleton report?

Mark Singleton reported exercising 13,000 restricted stock units into Class A common stock and a related tax-withholding disposition of 5,648 shares. These transactions reflect equity compensation vesting and associated tax settlement rather than open-market buying or selling activity.

How many Bioventus (BVS) shares does the CFO hold after this Form 4?

Following the reported equity compensation transactions, CFO Mark Singleton directly owns 182,981 shares of Bioventus Class A common stock. This total reflects the 13,000 shares received from restricted stock unit conversion and the 5,648 shares withheld to satisfy related tax obligations.

What does the tax-withholding disposition mean in the Bioventus (BVS) Form 4?

The tax-withholding disposition of 5,648 shares at $9.06 per share represents shares delivered to cover tax liabilities from vested awards. It is coded “F,” indicating a non‑market event distinct from an open‑market sale, and does not reflect a discretionary share sale.

What was the size of the restricted stock unit exercise for Bioventus (BVS) CFO?

The Form 4 shows that 13,000 restricted stock units were exercised into an equal number of Bioventus Class A shares at a conversion price of $0.00. Each RSU corresponds to one share, consistent with the equity award’s stated terms in the filing footnotes.

How do the Bioventus (BVS) RSU awards for the CFO vest over time?

The RSUs referenced vest in four equal installments on each of the first four anniversaries of April 10, 2023. Each installment requires the reporting person to continue in service through the applicable vesting date before the restricted stock units convert into common shares.